SECTOR
Remedium Lifecare’s arm partners with JiyaYu Lifesciences
May-09-2025

Remedium Lifecare’s subsidiary -- Remlife Global PTE has entered into strategic partnership with JiyaYu Lifesciences PTE, a green chemistry technology platform company. This collaboration is focused on replacing animal-origin raw materials in the manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates through proprietary fermentation and biocatalyst-based alternatives.

As part of the partnership, JiyaYu Lifesciences will license out fully developed and scalable technologies to Remlife Global on an exclusive basis. These technologies are designed to replace traditional animal-derived steps with sustainable, cost-effective, and regulatory compliant bioprocesses. Remlife Global will scale up and commercialise these technologies at one or more GMP-compliant contract manufacturing sites across India, Singapore, Malta, Ireland, Belgium, and Italy.

Each technology will be supported by detailed process dossiers and full technology transfer documents, enabling Remlife Global to implement, validate, and scale up the processes at approved GMP manufacturing sites. These solutions will support Remlife Global’s vision of eliminating dependence on vulnerable and ethically complex supply chains, while capturing new commercial opportunities in global regulated markets.

Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.


  RELATED NEWS >>